Bevacizumab as a surgery-sparing agent for spinal ependymoma in patients with neurofibromatosis type II: Systematic review and case
Publication date: April 2021Source: Journal of Clinical Neuroscience, Volume 86Author(s): M. Harrison Snyder, Leonel Ampie, Joseph D. DiDomenico, Ashok R. Asthagiri
Source: Journal of Clinical Neuroscience - Category: Neuroscience Source Type: research
More News: Avastin | Brain | Ependymoma | Neurofibromatosis | Neurology | Neuroscience | Neurosurgery